Randomized, double-blind, placebo-controlled phase I trial of pegylated megakaryocyte growth and development factor (PEG-rHuMGDF) administered to patients with advanced cancer before and after chemotherapy - Early results.
- Basser, R; Clarke, K; Fox, R; Green, M; Cebon, J; Marty, J; Menchaca, D; Tomita, D; Begley, G;
Publication Year 1995-11-15, Volume 86, Issue #10, Page 1014-1014
- Journal Title
- Publication Type
- Journal Article
- W B SAUNDERS CO
- Rights Notice
- Refer to copyright notice on published article.
Creation Date: 1995-11-15 12:00:00Last Modified: 0001-01-01 12:00:00